Dogwood Therapeutics
DWTX
15 hedge funds and large institutions have $4.91M invested in Dogwood Therapeutics in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
1% more capital invested
Capital invested by funds: $4.85M → $4.91M (+$53K)
0.07% more ownership
Funds ownership: 0.46% → 0.53% (+0.07%)
0% more funds holding
Funds holding: 15 → 15 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$546K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$102K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$69.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$52.5K |
| 5 |
CA
Cetera Advisors
Denver,
Colorado
|
+$46.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$5.09K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1.02K |
| 3 |
TIM
Tevis Investment Management
Plano,
Texas
|
-$1K |
| 4 |
Two Sigma Advisers
New York
|
-$582 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MCM
1
Masters Capital Management
Atlanta,
Georgia
| $2.91M | – | – | – |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $1.08M | +$546K | +3,752 | +63% |
|
|
CA
3
Cetera Advisors
Denver,
Colorado
| $197K | +$46.3K | +318 | +22% |
|
4
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $180K | – | – | – |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $141K | +$52.5K | +361 | +40% |
|
|
6
BlackRock
New York
| $80K | -$5.09K | -35 | -5% |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $78K | +$102K | +699 | New |
|
8
Northern Trust
Chicago,
Illinois
| $68K | – | – | – |
|
|
9
Two Sigma Advisers
New York
| $65K | -$582 | -4 | -0.7% |
|
|
10
UBS Group
Zurich,
Switzerland
| $63K | +$69.1K | +475 | +528% |
|
11
Morgan Stanley
New York
| $21K | +$27.1K | +186 | New |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| $12K | +$15.1K | +104 | +10,400% |
|
|
13
Osaic Holdings
Scottsdale,
Arizona
| $8K | -$1.02K | -7 | -9% |
|
|
TIM
14
Tevis Investment Management
Plano,
Texas
| – | -$1K | -3 | Closed |
|
DWTX Hedge Fund Activity: Q1 2022 in Review
15 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q1 2022, worth a combined $4.91M — up 1.1% from $4.85M a quarter earlier.
Fund positioning in DWTX was balanced in Q1 2022: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $546K. The largest seller was BlackRock, cutting an estimated $5.09K.
- 15 institutional investors held Dogwood Therapeutics (DWTX) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $4.91M of Dogwood Therapeutics stock for Q1 2022, up 1.1% quarter-over-quarter.
- 2 funds opened new Dogwood Therapeutics positions in Q1 2022 and 2 closed out, a net change of 0 holders.
- The largest Dogwood Therapeutics buyer in Q1 2022 was Vanguard Group, an estimated $546K added.
- The largest Dogwood Therapeutics seller in Q1 2022 was BlackRock, an estimated $5.09K sold.
Based on aggregated 13F filings for Q1 2022.